eprintid: 686
rev_number: 10
eprint_status: archive
userid: 2
dir: disk0/00/00/06/86
datestamp: 2011-07-01 10:02:40
lastmod: 2011-08-31 14:40:39
status_changed: 2011-07-01 10:02:40
type: article
metadata_visibility: show
item_issues_count: 0
creators_name: Pammolli, Fabio
creators_name: Riccaboni, Massimo
creators_id: f.pammolli@imtlucca.it
creators_id: massimo.riccaboni@imtlucca.it
title: Market Structure And Drug Innovation
ispublished: pub
subjects: HD
subjects: RM
divisions: EIC
full_text_status: none
abstract:  An explosion of knowledge and a growing array of tools and technologies have transformed modern drug R&D, while its cost has risen by a sizable amount. At the same time, the unchecked increase in health care and prescription drug spending has spawned cost containment policies that are restricting the demand for drugs in all major markets. This Perspective explores the interplay between technological advances and regulatory policies and their likely impact on the dynamics of the pharmaceutical industry. 
date: 2004
date_type: published
publication: Health Affairs
volume: 23
number: 1
pagerange: 48-50
id_number: 10.1377/hlthaff.23.1.48
refereed: TRUE
issn: 0278-2715
official_url: http://content.healthaffairs.org/content/23/1/48.full.pdf+html
citation:   Pammolli, Fabio and Riccaboni, Massimo  Market Structure And Drug Innovation.  Health Affairs, 23 (1).  pp. 48-50.  ISSN 0278-2715      (2004)